Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02824575
Brief Title: Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer

First Submitted : June 28, 2016
First Submitted that Met QC Criteria : July 1, 2016
First Posted : July 6, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 22, 2019
Last Update Posted : August 26, 2019